MedPath

Partial Sleep Restriction in Chronic Low Back Pain: A Feasibility Study

Active, not recruiting
Conditions
Chronic Low-back Pain
Insomnia
Sleep
Registration Number
NCT07008924
Lead Sponsor
University of Kansas Medical Center
Brief Summary

Our goal is to observational study is to determine feasibility of partial sleep restriction in individuals with CLBP+I and correlation findings with features of central sensitization.

* Identify feasibility of sleep restriction protocol

* Identify correlation between less sleep and central sensitization Sleep will be monitored for 2 weeks (baseline sleep monitoring period). Then participants will be asked to restrict their sleep to 80% of their normal sleep duration for 5 nights (sleep restriction period). Then sleep will be monitored again for 2 weeks (sleep recovery period).

Detailed Description

Actigraph and sleep diaries will be used to record sleep time and quality of sleep for 2 weeks baseline period. During this period several measures for pain, sleep, fatigue, cognition, and psychological status will be completed. Quantitative sensory testing will be used to establish pain threshold. Then, the participants will partial sleep restriction (20% sleep reduction/night for 5 nights). Following the completion of restricted sleep period, all outcome measures related to pain, sleep, fatigue, cognition, and psychological status will be assessed (post-sleep restriction assessment). Then participants' sleep will be monitored for 2-weeks (sleep recovery period). During the 5-night of sleep restriction, participants will be asked to complete electronic daily diary related to sleep, pain, fatigue, psychological distress and physical activity. Potential risk related to less sleep will be clearly explained to all potential individuals interested in participating.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria

• 25-65 years old individuals

Additional inclusion criteria for individuals with CLBP+I:

  • With or without insomnia
  • CLBP (LBP for at least 3 months with or without referred or radiating leg pain; pain intensity 1 or greater on 0 - 10 VAS scale
  • likely to participate in all scheduled evaluations and study procedures by self-report
  • agrees to abide by safely protocol e.g. not to drive or operate heavy machinery and perform heavy labor work, during the sleep-restriction period
Exclusion Criteria
  • spine compression, tumor, infection, history of spine surgery
  • neurological conditions such as stroke, Parkinson's disease, Alzheimer's disease or other cognitive impairments.
  • pregnancy
  • known untreated sleep disorder (such as current sleep apnea or current restless leg syndrome) screened by the following scales to ensure insomnia symptoms are due to insomnia and not another common sleep disorders:
  • Those with increased risk of sleep apnea
  • Increased risk of restless leg syndrome on RLS-Diagnosis Index
  • Increased risk of circadian rhythm sleep-wake disorder
  • Increased risk of parasomnia
  • Moderate level of depression identified by Patient Health Questionnaire (PHQ-9)
  • Moderate level of anxiety identify by Generalized Anxiety Disorder (GAD-7)
  • history of drug or alcohol abuse as defined by DSM-IV criteria within the last 2 years
  • severe mental illness such as schizophrenia or bipolar disorder
  • developmental history of learning disability or attention-deficit/hyperactivity disorder
  • is currently receiving CBT-I, physical therapy or chiropractic treatment
  • history of spinal surgery
  • current use of blood thinning medications
  • resting blood pressure greater than 160/90 mmHg40,49,50
  • performs overnight shift work

Additional exclusion criteria for HC individuals:

• pain rating 0 out of 0 - 10 Numeric Rating Pain Scale in any parts of the body

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sleep MeasuresThrough study completion, up to 5 weeks

Pittsburgh Sleep Quality

Pain MeasuresThrough study completion, up to 5 weeks

SF-McGill (MPQ),

Secondary Outcome Measures
NameTimeMethod
Sleep MeasuresThrough study completion, up to 5 weeks

Actigraphy- wearable sensor to record sleep quality and duration.

Psychological MeasuresThrough study completion, up to 5 weeks

Catastrophizing Scale (PCS)

Daily questionnaireThrough study completion, up to 5 weeks

For sleep restriction and recovery periods

Pain MeasuresThrough study completion, up to 5 weeks

Pinprick assessment

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.